Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BZ371A gel for female sexual arousal disorder
NCT06651541Phase 2Not yet recruiting
- Sponsor
- Biozeus
- Start
- Jul 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bz371a in Sexual Arousal Disorder, sponsored by Biozeus. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
bz371a
03
Conditions
Sexual Arousal Disorder
Beyond the preview
Go deeper on NCT06651541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06651541.